| Address |
2000-630 Boul. René-Lévesque Ouest Montréal, H3B 1S6 Canada |
|
| Address type | Registered Office Address | |
| Address province | Quebec |
| Corporation ID | 9019456 | |
| Business number | 835958596 | |
| Status | Active | |
| ACT | Canada Business Corporations Act | |
| Anniversary date | 09/15/2014 | |
| Last annual filing | 2025 | |
| Data verified | 10/31/2026 |
Location: Statistics Canada, Open Database of Addresses (Open Government Licence – Canada).
| Name | Effective date | Type | Current |
|---|---|---|---|
| GIIANT PHARMA INC. | 09/15/2014 | Corporate Name | true |
last updated: 2026-10-30
1 federal grant and contribution in 2021 with a total value of $345,000.
| Start date | Department and program | Value |
|---|---|---|
| 08/02/2021 |
National Research Council Canada Industrial Research Assistance Program – Contributions to Firms (contribution) The development of digestive tract-circumscribed PDE4 inhibitor prodrugs for the treatment of ulcerative colitis. Giiant Pharma develops new therapeutic for the gastrointestinal tract. The project aims to finalize the preclinical development and the production process to position the product for clinical trials. |
$345,000 |
Source: Government of Canada, proactive disclosure of grants and contributions. Contains information licensed under the Open Government Licence – Canada.
| Date | Type | Section |
|---|---|---|
| 06/13/2016 | Amendment | 6 |
| 09/15/2014 | Incorporation |
| Meeting date | Type of corporation | Year of filing |
|---|---|---|
| 06/15/2016 | Non-distributing corporation with 50 or fewer shareholders | 2016 |